Viewing Study NCT06953960

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-05-27 @ 10:15 PM
Study NCT ID: NCT06953960
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2025-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None ABBV-453 View
None Daratumumab View
None Dexamethasone View
None Pomalidomide View
None Cancer View